4//SEC Filing
RTW INVESTMENTS, LP 4
Accession 0001493152-21-007119
CIK 0001281895other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:01 PM ET
Size
9.2 KB
Accession
0001493152-21-007119
Insider Transaction Report
Form 4
RTW INVESTMENTS, LP
Director10% OwnerOther
Transactions
- Other
Common Stock
2021-03-24−1,344,925→ 16,185,119 total(indirect: See Footnote)
WONG RODERICK
Director10% Owner
Transactions
- Other
Common Stock
2021-03-24−1,344,925→ 16,185,119 total(indirect: See Footnote)
Yalamanchi Naveen
Director
Transactions
- Other
Common Stock
2021-03-24−1,344,925→ 16,185,119 total(indirect: See Footnote)
Footnotes (1)
- [F1]The reported securities were held by RTW Special Purpose Fund II, LLC ("SPF II"). RTW Investments, LP ("RTW") is the investment manager of SPF II. Roderick Wong, M.D., is the Managing Partner and Chief Investment Officer of RTW and is a director of the Issuer and Chairman of the Issuer's Board of Directors. Naveen Yalamanchi, M.D., is a Partner and Portfolio Manager of RTW and is a director of the Issuer. On March 24, 2021, SPF II made an in-kind distribution of the reported securities to its non-managing members. The distribution was consistent with SPF II's operating agreement and was made on a pro rata basis to all non-managing SPF II members. No consideration was received by the Reporting Persons in connection with such distribution. The Reporting Persons did not have any pecuniary interest in the Common Stock distributed by SPF II.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001493215
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:01 PM ET
- Size
- 9.2 KB